23
How we monitor the “Programme” Andrew Boulle, 1,2 1) Health Impact Assessment, Department of Health, Western Cape Province of South Africa 2) School of Public Health and Family Medicine, University of Cape Town, South Africa SA HIV Clinicians Society Conference, 13-16 April 2016

Slide Master Template

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Slide Master Template

How we monitor the “Programme”

Andrew Boulle,1,2

1) Health Impact Assessment, Department of Health, Western Cape Province of South Africa

2) School of Public Health and Family Medicine, University of Cape Town, South Africa

SA HIV Clinicians Society Conference, 13-16 April 2016

Page 2: Slide Master Template

Hierarchy of intent

Clinical care Identify where or with whom to intervene

• Missed appointments or disengaged from care

• Suboptimal monitoring or treatment

• Clinical risk mitigation

Quality of care and clinical governance • Audits, morbidity and mortality surveillance

Manage programme performance at each level Key outcome metrics

• within facility, across facilities, across subdistricts, etc.

• Cohort reports on enrolment, retention, virologic completion

Resource allocation • Monthly reports on enrolments and retention

Strategic information to inform programme design and evolution • True outcomes and impact, required occasionally not continuously

• Cohort studies, surveys, occasional large data exercises

• Morbidity and mortality surveillance

Patient

Facility

Province

National

Page 3: Slide Master Template

Linking what we do to the hierarchy

Three Tier System (Patient information system)

• reports at facility level for patient

management

• outputs (monthly) and outcomes

(quarterly) for facility management

Other data sources • Household surveys (4-yearly)

• Resistance surveillance

• Consolidated laboratory data; drug procurement

• Thembisa model

• Cohort studies

• Vital registration, morbidity surveillance

Page 4: Slide Master Template

The three-tier approach to ART monitoring

Source: Osler, JIAS 2014

Page 5: Slide Master Template

Current challenges with routine

monitoring

Page 6: Slide Master Template

Dynamic patient population

Enrolment

True LTF

Silent transfers and interrupters

Silent transfers and return to care

Exaggerated LTF

Exaggerated enrolment

Retained in care more robust

Page 7: Slide Master Template

Number of people on ART in South Africa

0

500 000

1 000 000

1 500 000

2 000 000

2 500 000

3 000 000

3 500 000

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Nu

mb

ers

of

pat

ien

ts o

n a

nti

retr

ovi

ral t

reat

men

t

DHIS (public sector only) THEMBISA Model (pub+pvt) UNGASS reports public sector CCMT 2009 report National HIV household survey

NHLS viral loads* (adjusted 1/0.75) Johnson 2012 (Public sector)

3 094 896 patients on public sector ART, end March 2015

*Carmona, Bronze, MacLeod: Monitoring and Evaluation of Effectiveness of CCMT Programme

Page 8: Slide Master Template

Viral load completion and suppression

30.0

40.0

50.0

60.0

70.0

80.0

90.0

100.0

6 12 24 36 48 60

Duration on ART in months

Viral load completion (VLD) and suppression (VLS)

Reported 2012/13 Reported 2013/14

Reported 2014/15

Page 9: Slide Master Template

Viral load testing loop

Blood taken

Result

returned to

facility

Got to lab

and tested

Result in

folder

Result seen by

clinician

Result in

clinical record

keeping

Result

transcribed

into register

Management

information

Page 10: Slide Master Template

Where to integrate automated results retrieval

Registry /

front desk

Observation

room

Clinical area

Registry /

backoffice

Pharmacy

Clinical area Clinical area

Clinical area Clinical areas

PMI On-the –fly

results retrieval

Page 11: Slide Master Template

Opportunities

Page 12: Slide Master Template

If we can get connectivity right then

PMI and patient registration essential first step Ensures all data no matter how and when transferred, are linkable

Results retrieval on the fly on patient arrival Strengthen the PMI and patient flow past registry on arrival

Properly printed pathologist signed reports, printed and filed on the fly, placed on

the top of the folder, available to clinician and backoffice

Data collected by backend systems (lab, TIER.Net, RxSolution), much more readily

linkable no matter how it is transferred upwards

Opportunity to test, mature and assess infrastructure readiness for….

1. Aggressive expansion of the PMI

Page 13: Slide Master Template

With better linkage and patient identifiers we can pursue Increased interoperability of TIER 2 systems

HPRS / PMI integration

Connection to health exchanges for retrieval and sharing of clinical

data, including laboratory and encounters with the intention of

improving the quality and efficiency of reports for local patient and

facility management

As stability improves and infrastructure matures, readiness for a TIER 3 (networked) system can be properly assessed, and migration can be

incremental

Avoid multiple electronic patient information systems in the same facility

Ensure a single TIER 3 system within entire jurisdictions, linked to HIS

strategy and enterprise primary care system

Identify the right tipping point

2. Move towards an enterprise (TIER 3) PIS with intent

Page 14: Slide Master Template

3. Person-level data, keep it simple and coherent

Routinely collected person level information

Three potential sources, stick to two Patient information systems

Laboratory systems

Event based data specially collected

• Dedicated registers

• Notification (sometimes referred to as case-based

surveillance)

Add value, limit dependency, until mature Reports; Query engines/ API’s for hybrid systems

Single-patient viewer

Follow a federated health exchange model

Responsible party is the deliverer of care

Pass through curated data from province to national

Clear understanding of difference between information for

clinical care, facility management and strategic purposes

Page 15: Slide Master Template

Ho

ldin

g

Ho

use

ho

ld

Faci

lity

Source archive

Clinicom

PHCIS/EKAPA

TIER/ETR/EDR

JAC/CDU

NHLS

PACS/ECM

Mortality

Clin

ical

Pa

tien

t

Stag

ing

Sources* Extract, Transform, Load, Curate Repositories

An

on

ymo

us

view

(s)

An

alys

is v

iew

(a

no

nym

ou

s)

Access

SP la

yer

for

con

nee

cto

rs PPIP/CHIP

Prehmis

mHealth Op

enH

IM

(rea

l-ti

me)

D

aily

or

pe

rio

dic

dat

abas

e p

ulls

o

r lo

adin

g o

f ex

po

rts

Op

enH

IM

Clin

ical

vie

w

Ap

plic

atio

ns

(e

g. S

PV,

PH

CIS

)

* No record is ever changed in any source system

High level architecture and data load process

Op

erat

ion

al r

epo

ts

(eg.

Sh

arep

oin

t)

An

alys

ts

Person

Place

Code

Core tables

Lookup tables

Mapping tables

Encounters

Episodes

Page 16: Slide Master Template

4. Digitise HIV testing (and all point of care tests)

Leverage the incredible LIS

Avoid new case registers

Audit trail in the facility, send a copy with other specimens

Remunerate the laboratory for data capture

Ensure dedicated test codes so as not to hold the NHLS

responsible for test quality, and clearly identify as PoC tests in

results retrieval

Benefits Tests for the whole cascade on one system

Can replace testing registers

Triangulate with patient information systems as they start capturing

broader HIV care (e.g TIER.Net HCT module)

Huge benefit to health exchange / centralised data

Page 17: Slide Master Template

5. New cohort data elements

Interruptions (ITR)

Return to care (RET)

Benefits

Temporally stable metrics on time to first loss

Ability to follow “

Page 18: Slide Master Template

Comparing trends to first versus current loss to care status

Loss to follow-up or death by calendar period

0.0

00

.10

0.2

00

.30

0.4

00

.50

Cum

ula

tive p

roport

ion lo

st to

care

0 1 2 3 4 5 6 7

Duration on ART in years

Time to death or first LTF

0.0

00

.10

0.2

00

.30

0.4

00

.50

0 1 2 3 4 5 6 7

Duration on ART in years

2010-122007-92004-6

Time to death or LTF as defined mid-2012

Based on 30,000 patients from Khayelithsa, South Africa

Page 19: Slide Master Template

6. Mortality and morbidity surveillance

Link mortality and cause of death into the

nascent health exchanges

Work backwards to find missed opportunities

where we see Deaths

HIV associated events

40% of deaths in 2012 in the WC were in patients who were

previously on ART

60% of medical inpatients in a WC district hospital in 2012 were

HIV-infected, 2/3 ART exposed (Meintjes 2015)

M&M approach common to many conditions, but with

a population focus

what went wrong anywhere in the system prior to the event

Page 20: Slide Master Template

Impact of ART on adult survival – total deaths by age and year

Source: Rapid mortality surveillance report 2013: SA MRC: Dorrington, Bradshaw, Laubscher, Nannan

Page 21: Slide Master Template

Summary

Page 22: Slide Master Template

Linking what we do to the hierarchy

Three Tier System (Patient information system)

• reports at facility level for patient

management

• outputs (monthly) and outcomes

(quarterly) for facility management

Other data sources • Household surveys (4 yearly)

• Resistance surveillance

• Consolidated laboratory data; drug procurement

• Thembisa model

• Cohort studies

• Vital registration, morbidity surveillance

Page 23: Slide Master Template

Proposals

Expansion of the PMI / patient registrstion systems

Incremental transition to TIER 3 until tipping point

reached

Clear approach to integration and use of person-level

data linked to nascent health information exchange

aspirations

Digitise point of care tests

New cohort data elements

Person level mortality and morbidity surveillance

linkable to other service data